Botikov相关文献与解析，生知库 | 链接生命科学的每一步

Irina A Favorskaya, Dmitry V Shcheblyakov, Ilias B Esmagambetov, Inna V Dolzhikova, Irina A Alekseeva, Anastasia I Korobkova, Daria V Voronina, Ekaterina I Ryabova, Artem A Derkaev, Anna V Kovyrshina, Anna A Iliukhina, Andrey G Botikov, Olga L Voronina, Daria A Egorova, Olga V Zubkova, Natalia N Ryz

代谢

免疫

心血管

新冠

发表日期：2022

文献求助收藏

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

基于rAd26和rAd5载体的异源性新冠疫苗的安全性和有效性：一项在俄罗斯开展的随机对照3期临床试验的中期分析

期刊:Lancet

影响因子:88.5

doi:10.1016/S0140-6736(21)00234-8

Logunov, Denis Y; Dolzhikova, Inna V; Shcheblyakov, Dmitry V; Tukhvatulin, Amir I; Zubkova, Olga V; Dzharullaeva, Alina S; Kovyrshina, Anna V; Lubenets, Nadezhda L; Grousova, Daria M; Erokhova, Alina S; Botikov, Andrei G; Izhaeva, Fatima M; Popova, Olga; Ozharovskaya, Tatiana A; Esmagambetov, Ilias B; Favorskaya, Irina A; Zrelkin, Denis I; Voronina, Daria V; Shcherbinin, Dmitry N; Semikhin, Alexander S; Simakova, Yana V; Tokarskaya, Elizaveta A; Egorova, Daria A; Shmarov, Maksim M; Nikitenko, Natalia A; Gushchin, Vladimir A; Smolyarchuk, Elena A; Zyryanov, Sergey K; Borisevich, Sergei V; Naroditsky, Boris S; Gintsburg, Alexander L

An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine "Sputnik Light" for prevention of coronavirus infection in healthy adults

一项开放标签、非随机、1/2期临床试验，旨在评估单剂量疫苗“Sputnik Light”在健康成人中预防冠状病毒感染的安全性、耐受性和免疫原性。

期刊:Lancet Regional Health-Europe

影响因子:13

doi:10.1016/j.lanepe.2021.100241

Tukhvatulin, Amir I; Dolzhikova, Inna V; Shcheblyakov, Dmitry V; Zubkova, Olga V; Dzharullaeva, Alina S; Kovyrshina, Anna V; Lubenets, Nadezhda L; Grousova, Daria M; Erokhova, Alina S; Botikov, Andrei G; Izhaeva, Fatima M; Popova, Olga; Ozharovskaia, Tatiana A; Esmagambetov, Ilias B; Favorskaya, Irina A; Zrelkin, Denis I; Voronina, Daria V; Shcherbinin, Dmitry N; Semikhin, Alexander S; Simakova, Yana V; Tokarskaya, Elizaveta A; Shmarov, Maksim M; Nikitenko, Natalia A; Gushchin, Vladimir A; Smolyarchuk, Elena A; Zubkova, Tatiana G; Zakharov, Konstantin A; Vasilyuk, Vasiliy B; Borisevich, Sergei V; Naroditsky, Boris S; Logunov, Denis Y; Gintsburg, Alexander L

A Case of Moderately Severe COVID-19 in a Healthcare Worker in Russia: Virus Isolation and Full Genome Sequencing

俄罗斯一名医护人员感染中度至重症新冠肺炎病例：病毒分离和全基因组测序

期刊:Cureus Journal of Medical Science

影响因子:1.3

doi:10.7759/cureus.13733

Shchetinin, Alexey M; Tsyganova, Elena V; Protsenko, Denis N; Botikov, Andrey G; Gushchin, Vladimir

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

两种配方的基于rAd26和rAd5载体的异源性新冠疫苗的安全性和免疫原性：两项来自俄罗斯的开放性、非随机1/2期研究

期刊:Lancet

影响因子:88.5

doi:10.1016/S0140-6736(20)31866-3

Logunov, Denis Y; Dolzhikova, Inna V; Zubkova, Olga V; Tukhvatullin, Amir I; Shcheblyakov, Dmitry V; Dzharullaeva, Alina S; Grousova, Daria M; Erokhova, Alina S; Kovyrshina, Anna V; Botikov, Andrei G; Izhaeva, Fatima M; Popova, Olga; Ozharovskaya, Tatiana A; Esmagambetov, Ilias B; Favorskaya, Irina A; Zrelkin, Denis I; Voronina, Daria V; Shcherbinin, Dmitry N; Semikhin, Alexander S; Simakova, Yana V; Tokarskaya, Elizaveta A; Lubenets, Nadezhda L; Egorova, Daria A; Shmarov, Maksim M; Nikitenko, Natalia A; Morozova, Lola F; Smolyarchuk, Elena A; Kryukov, Evgeny V; Babira, Vladimir F; Borisevich, Sergei V; Naroditsky, Boris S; Gintsburg, Alexander L

Preclinical Studies of Immunogenity, Protectivity, and Safety of the Combined Vector Vaccine for Prevention of the Middle East Respiratory Syndrome.

预防中东呼吸综合征联合载体疫苗的免疫原性、保护性和安全性的临床前研究

期刊:Acta Naturae

影响因子:2

doi:10.32607/actanaturae.11042

Dolzhikova I V, Grousova D M, Zubkova O V, Tukhvatulin A I, Kovyrshina A V, Lubenets N L, Ozharovskaia T A, Popova O, Esmagambetov I B, Shcheblyakov D V, Evgrafova I M, Nedorubov A A, Gordeichuk I V, Gulyaev S A, Botikov A G, Panina L V, Mishin D V, Loginova S Y, Borisevich S V, Deryabin P G, Naroditsky B S, Logunov D Y, Gintsburg A L

其它

发表日期：2020

文献求助收藏

Genetic and Phylogenetic Characterization of Tataguine and Witwatersrand Viruses and Other Orthobunyaviruses of the Anopheles A, Capim, Guamá, Koongol, Mapputta, Tete, and Turlock Serogroups

塔塔吉病毒和威特沃特斯兰德病毒以及按蚊 A、卡皮姆、瓜马、孔戈尔、马普塔、特特和特洛克血清群的其他正布尼亚病毒的遗传和系统发育特征

期刊:Viruses-Basel

影响因子:3.8

doi:10.3390/v7112918

Alexey M Shchetinin, Dmitry K Lvov, Petr G Deriabin, Andrey G Botikov, Asya K Gitelman, Jens H Kuhn, Sergey V Alkhovsky

微生物学

发表日期：2015

文献求助收藏

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern

单域抗体可有效中和令人担忧的 SARS-CoV-2 变体

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

基于rAd26和rAd5载体的异源性新冠疫苗的安全性和有效性：一项在俄罗斯开展的随机对照3期临床试验的中期分析

An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine "Sputnik Light" for prevention of coronavirus infection in healthy adults

一项开放标签、非随机、1/2期临床试验，旨在评估单剂量疫苗“Sputnik Light”在健康成人中预防冠状病毒感染的安全性、耐受性和免疫原性。

A Case of Moderately Severe COVID-19 in a Healthcare Worker in Russia: Virus Isolation and Full Genome Sequencing

俄罗斯一名医护人员感染中度至重症新冠肺炎病例：病毒分离和全基因组测序

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

两种配方的基于rAd26和rAd5载体的异源性新冠疫苗的安全性和免疫原性：两项来自俄罗斯的开放性、非随机1/2期研究

Preclinical Studies of Immunogenity, Protectivity, and Safety of the Combined Vector Vaccine for Prevention of the Middle East Respiratory Syndrome.

预防中东呼吸综合征联合载体疫苗的免疫原性、保护性和安全性的临床前研究

Genetic and Phylogenetic Characterization of Tataguine and Witwatersrand Viruses and Other Orthobunyaviruses of the Anopheles A, Capim, Guamá, Koongol, Mapputta, Tete, and Turlock Serogroups

塔塔吉病毒和威特沃特斯兰德病毒以及按蚊 A、卡皮姆、瓜马、孔戈尔、马普塔、特特和特洛克血清群的其他正布尼亚病毒的遗传和系统发育特征